Cleveland Clinic Cancer Advances

Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Institute, joins the Cancer Advances podcast to discuss the latest advancements in immunotherapy for aggressive lymphomas. Listen as Dr. Caimi talks about the potential of bispecific antibody combinations, including early-phase findings on glofitamab plus ICE chemotherapy for relapsed and refractory diffuse large B-cell lymphoma.